30 YangH.ChenC.ChenH.DuanX.LiJ.ZhouY.et al (2020)
Given the expanding clinical use of GLP-1 receptor agonists, particularly in younger and non-diabetic populations, timely evidence is needed to inform clinical practice and regulatory decisions, said the authors
(PubMed) Penney KL, Schumacher FR, Li H, et al
Journal paper reviewed in full
Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study
Its easy to sign up to receive informational emails about SOLIQUA 100/33 and living with diabetes powered by TeamingUp